NDRA vs VTR · P/E 0.0, $2.6M cap vs P/E 149, rev $4.92B
ENDRA Life Sciences Inc (NDRA) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
NDRA does not have a complete income-statement cache yet.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
NDRA currently screens at market cap $2.6M and trailing P/E 0.0. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the NDRA and VTR stock pages for the full models.
Not investment advice.